Established in 2005, Guilin Hwasun Pharmaceutical has become a prominent enterprise producing generic active pharmaceutical ingredients and formulations, with a GMP-approved facility and strong regulatory support that has enabled its products to enter global markets including the EU, Asia and South America, contributing to global healthcare advancement for nearly two decades.

No comments available.
Leave your rating & comment